Skip to main content
Erschienen in: European Radiology 4/2015

01.04.2015 | Interventional

Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours

verfasst von: Jie Yu, Ping Liang, Xiao-ling Yu, Zhi-gang Cheng, Zhi-yu Han, Meng-juan Mu, Qin-ying Li, Yan-mei Liu

Erschienen in: European Radiology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To identify the incidence and risk factors that predict local tumour progression (LTP) after ultrasound-guided percutaneous microwave ablation (MWA) of liver malignancies.

Materials and Methods

One thousand two hundred and nine patients with 2,529 malignant nodules (mean size 2.8 ± 1.4 cm, range 0.9-8.0 cm) were treated by MWA between July 2005 and December 2012. The influence of 11 factors on the risk of LTP was assessed. Univariate Kaplan-Meier and Cox proportional hazard models were used for statistical analysis.

Results

The overall LTP was 4.2 % per tumour and 8.6 % per patient with a median follow-up of 20.3 months. LTP per tumour was 4.3 % for primary liver cancer and 4.1 % for metastases (p = 0.32). The survival of LTP and free-LTP patients at 1, 3, and 5 years was 92.4 %, 71.6 %, and 45.1 %, respectively, and 92.9 %, 70.1 %, and 52.4 %, respectively (p = 0.93). By univariate analysis, tumour location, size and ablation time were significant risk factors of LTP. Multivariate analysis identified tumour size (>3.0 cm) to be the only independent predictor of LTP.

Conclusions

MWA of liver malignancies achieves a relatively low-incidence LTP, although LTP risk significantly increases if tumour size >3.0 cm. The technique seems to be appropriate even for patients with a tumour at a risk location.

Key Points

• Microwave ablation of liver malignancies achieves a low incidence local tumour progression.
• LTP risk significantly increases if the tumour size is >3.0 cm.
• MWA seems to be appropriate even for patients with a tumour at a risk location.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed
2.
Zurück zum Zitat Kumada T, Nakano S, Takeda I et al (1997) Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 25:87–92CrossRefPubMed Kumada T, Nakano S, Takeda I et al (1997) Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 25:87–92CrossRefPubMed
3.
Zurück zum Zitat Okuda K, Ohtsuki T, Obata H, Tomimatsu M et al (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 56:918–928CrossRefPubMed Okuda K, Ohtsuki T, Obata H, Tomimatsu M et al (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 56:918–928CrossRefPubMed
4.
Zurück zum Zitat Lam VW, Ng KK, Chok KS et al (2008) Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg 207:20–29CrossRefPubMed Lam VW, Ng KK, Chok KS et al (2008) Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg 207:20–29CrossRefPubMed
5.
6.
Zurück zum Zitat Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430CrossRefPubMed Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430CrossRefPubMed
7.
Zurück zum Zitat Makuuchi M, Kokudo N, Arii S et al (2008) Development of evidencebased clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 38:37–51CrossRefPubMed Makuuchi M, Kokudo N, Arii S et al (2008) Development of evidencebased clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 38:37–51CrossRefPubMed
8.
Zurück zum Zitat Mima K, Beppu T, Chikamoto A, et al (2013) Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence. Int J Clin Oncol 18(5):847–855 Mima K, Beppu T, Chikamoto A, et al (2013) Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence. Int J Clin Oncol 18(5):847–855
9.
Zurück zum Zitat Xia F, Lai EC, Lau WY et al (2012) High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small hepatocellular carcinoma. Ann Surg Oncol 19:1284–1291CrossRefPubMed Xia F, Lai EC, Lau WY et al (2012) High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small hepatocellular carcinoma. Ann Surg Oncol 19:1284–1291CrossRefPubMed
10.
Zurück zum Zitat Berber E, Siperstein A (2008) Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Ann Surg Oncol 15:2757–2764CrossRefPubMed Berber E, Siperstein A (2008) Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Ann Surg Oncol 15:2757–2764CrossRefPubMed
11.
Zurück zum Zitat Eisele RM, Schumacher G, Neuhaus P (2008) Local recurrence following hepatic radiofrequency ablation: diagnosis and treatment. Strahlenther Onkol 184:598–604CrossRefPubMed Eisele RM, Schumacher G, Neuhaus P (2008) Local recurrence following hepatic radiofrequency ablation: diagnosis and treatment. Strahlenther Onkol 184:598–604CrossRefPubMed
12.
Zurück zum Zitat Kei SK, Rhim H, Choi D, Lee WJ, Lim HK, Kim YS (2008) Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am J Roentgenol 190:1544–1551CrossRefPubMed Kei SK, Rhim H, Choi D, Lee WJ, Lim HK, Kim YS (2008) Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am J Roentgenol 190:1544–1551CrossRefPubMed
13.
Zurück zum Zitat Nishikawa H, Inuzuka T, Takeda H et al (2011) Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation. J Gastroenterol 46:1418–1426CrossRefPubMed Nishikawa H, Inuzuka T, Takeda H et al (2011) Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation. J Gastroenterol 46:1418–1426CrossRefPubMed
14.
Zurück zum Zitat Nakazawa T, Kokubu S, Shibuya A et al (2007) Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 188:480–488CrossRefPubMed Nakazawa T, Kokubu S, Shibuya A et al (2007) Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 188:480–488CrossRefPubMed
15.
Zurück zum Zitat Ayav A, Germain A, Marchal F et al (2010) Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence. Am J Surg 200:435–439CrossRefPubMed Ayav A, Germain A, Marchal F et al (2010) Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence. Am J Surg 200:435–439CrossRefPubMed
16.
Zurück zum Zitat Komorizono Y, Oketani M, Sako K et al (2003) Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 97:1253–1262CrossRefPubMed Komorizono Y, Oketani M, Sako K et al (2003) Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 97:1253–1262CrossRefPubMed
17.
Zurück zum Zitat Hori T, Nagata K, Hasuike S et al (2003) Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 38:977–981CrossRefPubMed Hori T, Nagata K, Hasuike S et al (2003) Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 38:977–981CrossRefPubMed
18.
Zurück zum Zitat Liang P, Yu J, Yu X-l, Wang X, Wei Q, Yu S (2011) Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: a multicentre analysis of 1363 treatment-naive lesions in 1007 patients in China. Gut 61:1100–1101CrossRefPubMed Liang P, Yu J, Yu X-l, Wang X, Wei Q, Yu S (2011) Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: a multicentre analysis of 1363 treatment-naive lesions in 1007 patients in China. Gut 61:1100–1101CrossRefPubMed
19.
Zurück zum Zitat Swan RZ, Sindram D, Martinie JB, Iannitti DA (2013) Operative microwave ablation for hepatocellular carcinoma: complications, recurrence, and long-term outcomes. J Gastrointest Surg 17:719–729CrossRefPubMed Swan RZ, Sindram D, Martinie JB, Iannitti DA (2013) Operative microwave ablation for hepatocellular carcinoma: complications, recurrence, and long-term outcomes. J Gastrointest Surg 17:719–729CrossRefPubMed
20.
Zurück zum Zitat Lorentzen T, Skjoldbye BO, Nolsoe CP (2011) Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients. Ultraschall Med 32:492–496CrossRefPubMed Lorentzen T, Skjoldbye BO, Nolsoe CP (2011) Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients. Ultraschall Med 32:492–496CrossRefPubMed
21.
Zurück zum Zitat Bhardwaj N, Strickland AD, Ahmad F et al (2010) Microwave ablation for unresectable hepatic tumours: clinical results using a novel microwave probe and generator. Eur J Surg Oncol 36:264–268CrossRefPubMed Bhardwaj N, Strickland AD, Ahmad F et al (2010) Microwave ablation for unresectable hepatic tumours: clinical results using a novel microwave probe and generator. Eur J Surg Oncol 36:264–268CrossRefPubMed
22.
Zurück zum Zitat Martin RC, Scoggins CR, McMasters KM (2010) Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol 17:171–178CrossRefPubMed Martin RC, Scoggins CR, McMasters KM (2010) Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol 17:171–178CrossRefPubMed
23.
Zurück zum Zitat Yu J, Liang P, Xiaoling Y, Liu F, Chen L, Wang Y (2011) A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: results in ex vivo and in vivo porcine livers. Eur J Radiol 79:124–130CrossRefPubMed Yu J, Liang P, Xiaoling Y, Liu F, Chen L, Wang Y (2011) A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: results in ex vivo and in vivo porcine livers. Eur J Radiol 79:124–130CrossRefPubMed
24.
Zurück zum Zitat Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRefPubMed Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRefPubMed
25.
Zurück zum Zitat Ahmed M, Solbiati L, Brace CL et al (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria—A 10-year update. Radiology 13, 132958 Ahmed M, Solbiati L, Brace CL et al (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria—A 10-year update. Radiology 13, 132958
26.
Zurück zum Zitat Liang P, Dong B, Yu X et al (2005) Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 235:299–307CrossRefPubMed Liang P, Dong B, Yu X et al (2005) Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 235:299–307CrossRefPubMed
27.
Zurück zum Zitat Liang P, Dong B, Yu X et al (2003) Prognostic factors for percutaneous microwave coagulation therapy of hepatic metastases. AJR Am J Roentgenol 181:1319–1325CrossRefPubMed Liang P, Dong B, Yu X et al (2003) Prognostic factors for percutaneous microwave coagulation therapy of hepatic metastases. AJR Am J Roentgenol 181:1319–1325CrossRefPubMed
28.
Zurück zum Zitat Poggi G, Montagna B, DI Cesare P et al (2013) Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results. Anticancer Res 33:1221–1227PubMed Poggi G, Montagna B, DI Cesare P et al (2013) Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results. Anticancer Res 33:1221–1227PubMed
29.
Zurück zum Zitat Murakami T, Ishimaru H, Sakamoto I et al (2007) Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence. Cardiovasc Intervent Radiol 30:696–704CrossRefPubMed Murakami T, Ishimaru H, Sakamoto I et al (2007) Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence. Cardiovasc Intervent Radiol 30:696–704CrossRefPubMed
30.
Zurück zum Zitat Ierardi AM, Floridi C, Fontana F et al (2013) Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation. Radiol Med 118:949–961CrossRefPubMed Ierardi AM, Floridi C, Fontana F et al (2013) Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation. Radiol Med 118:949–961CrossRefPubMed
31.
Zurück zum Zitat Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS (1999) Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210:655–661CrossRefPubMed Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS (1999) Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210:655–661CrossRefPubMed
32.
Zurück zum Zitat Horigome H, Nomura T, Saso K, Itoh M (1999) Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence. Am J Gastroenterol 94:1914–1917CrossRefPubMed Horigome H, Nomura T, Saso K, Itoh M (1999) Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence. Am J Gastroenterol 94:1914–1917CrossRefPubMed
33.
Zurück zum Zitat Okusaka T, Okada S, Ueno H et al (2002) Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer 95:1931–1937CrossRefPubMed Okusaka T, Okada S, Ueno H et al (2002) Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer 95:1931–1937CrossRefPubMed
34.
Zurück zum Zitat Takahashi S, Kudo M, Chung H et al (2007) Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 72:98–103CrossRefPubMed Takahashi S, Kudo M, Chung H et al (2007) Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 72:98–103CrossRefPubMed
35.
Zurück zum Zitat Lee HY, Rhim H, Lee MW et al (2013) Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors. Eur Radiol 23:190–197CrossRefPubMed Lee HY, Rhim H, Lee MW et al (2013) Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors. Eur Radiol 23:190–197CrossRefPubMed
Metadaten
Titel
Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours
verfasst von
Jie Yu
Ping Liang
Xiao-ling Yu
Zhi-gang Cheng
Zhi-yu Han
Meng-juan Mu
Qin-ying Li
Yan-mei Liu
Publikationsdatum
01.04.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 4/2015
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3483-4

Weitere Artikel der Ausgabe 4/2015

European Radiology 4/2015 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.